KIR3DL1 and COVID-19: Research on COVID-19 should include KIR-HLA sequence variants, including their arrangements on recognition, signaling, development, receptor-ligand expression, effector function, and impact on disease susceptibility and resistance, especially understanding how the genetic diversity of HLA and KIR haplotypes impact the disease progression of COVID-19 and aid in identifying high-risk individuals.